<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02965300</url>
  </required_header>
  <id_info>
    <org_study_id>S2016-110-01</org_study_id>
    <nct_id>NCT02965300</nct_id>
  </id_info>
  <brief_title>The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis</brief_title>
  <acronym>VOCs</acronym>
  <official_title>The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to analysis the volatile organic gases(VOCs) in exhaled breath
      of pulmonary lesion patients and healthy controls, in order to find the difference of
      composition and concentration among groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Collect the exhaled gas in pulmonary lesion patients and healthy controls, using proton
      transfer reaction mass spectrometry to analysis the different composition and concentration
      of VOCs, to find the biomarker gases of distinguishing benign and malignant lesion of lung
      among different groups， and try to build a diagnostic model for lung lesion.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mass-to-charge Ratio</measure>
    <time_frame>6 months</time_frame>
    <description>It is the measurement result of VOCs in exhaled breath using PTR-MS device.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">230</enrollment>
  <condition>Lung Neoplasm</condition>
  <condition>Lung Disease</condition>
  <arm_group>
    <arm_group_label>Primary lung cancer</arm_group_label>
    <description>patients newly diagnosed with lung cancer by tissue biopsy and did not receive any treatment aiming at the tumor, including chemotherapy and radiotherapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Benign lung lesion</arm_group_label>
    <description>Patients diagnosed with pulmonary benign diseases.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control</arm_group_label>
    <description>Patients without any pulmonary abnormal symptoms or diseases</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Exhaled breath
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with lung disease or healthy controls without lung diseases， and can
        cooperate with the collection of exhaled breath.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cohort 1 :

        Inclusion criteria:

        Patients newly diagnosed with primary lung cancer by tissue biopsy and did not receive any
        treatment aiming at the tumor, including chemotherapy and radiotherapy.

        Age ≥ 18 years

          -  cohort 2： Inclusion criteria： Patients diagnosed with pulmonary benign lesion by
             tissue biopsy or other examination.

        Age ≥ 18 years

        Exclusion Criteria:

        patients who have more than one type of carcinoma patients diagnosed type 2 diabetes
        mellitus patients diagnosed chronic renal failure patients diagnosed upper digestive tract
        ulcer patients who reject to sign the informed consent from

          -  cohort 3： Healthy controls Volunteers without diagnosed lung diseases and pulmonary
             symptoms.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>liang-an Chen, MD,PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liang—an Chen, MD,PHD</last_name>
    <phone>8610-55499027</phone>
    <email>cla301@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>department of respiratory department ,Chinese PLA general hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liang-an Chen, MD,PHD</last_name>
      <phone>8610-55499027</phone>
      <email>cla301@126.com</email>
    </contact>
    <investigator>
      <last_name>Liang-an Chen, MD,PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2016</study_first_submitted>
  <study_first_submitted_qc>November 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2016</study_first_posted>
  <last_update_submitted>November 14, 2016</last_update_submitted>
  <last_update_submitted_qc>November 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Chen Liang_An</investigator_full_name>
    <investigator_title>MD,PHD</investigator_title>
  </responsible_party>
  <keyword>Pulmonary lesion</keyword>
  <keyword>Volatile Organic Compositions(VOCs)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>considering of personal privacy, the research-related individual participant data do not intend for public sharing.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

